Journal Article

Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis

Tamaro S. Hudson, Bradley A. Carlson, Mark J. Hoeneroff, Heather A. Young, Lorraine Sordillo, William J. Muller, Dolph L. Hatfield and Jeffrey E. Green

in Carcinogenesis

Volume 33, issue 6, pages 1225-1230
Published in print June 2012 | ISSN: 0143-3334
Published online March 2012 | e-ISSN: 1460-2180 | DOI:
Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Selenium is an essential micronutrient in the diet of humans and other mammals. Based largely on animal studies and epidemiological evidence, selenium is purported to be a promising cancer chemopreventive agent. However, the biological mechanisms by which chemopreventive activity takes place are poorly understood. It remains unclear whether selenium acts in its elemental form, through incorporation into organic compounds, through selenoproteins or any combination of these. The purpose of this study was to determine whether selenoproteins mitigate the risk of developing chemically induced mammary cancer. Selenoprotein expression was ablated in mouse mammary epithelial cells through genetic deletion of the selenocysteine (Sec) tRNA gene (Trsp), whose product, designated selenocysteine tRNA, is required for selenoprotein translation. Trsp floxed and mouse mammary tumor virus (MMTV)-cre mice were crossed to achieve tissue-specific excision of Trsp in targeted mammary glands. Eight- to twelve-week-old second generation Trspfl/+ ;wt, Trspfl/+ ;MMTV-cre, Trsp fl/fl ;wt and Trspfl/fl ;MMTV-cre female mice were administered standard doses of the carcinogen, 7,12-dimethylbenzylbenz[a]antracene. Our results revealed that heterozygous, Trspfl/+ ;MMTV-cre mice showed no difference in tumor incidence, tumor rate and survival compared with the Trspfl/+ ;wt mice. However, 54.8% of homozygous Trspfl/f l;MMTV-cre mice developed mammary tumors and exhibited significantly shorter survival than the corresponding Trspfl/fl ;wt mice, where only 36.4% developed tumors. Loss of the homozygous Trsp alleles was associated with the reduction of selenoprotein expression. The results suggest that mice with reduced selenoprotein expression have increased susceptibility to developing carcinogen-induced mammary tumors and that a major protective mechanism against carcinogen-induced mammary cancer requires the expression of these selenoproteins.

Journal Article.  5164 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.